SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Anthony @ Equity Investigations, Dear Anthony,

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Anthony@Pacific who wrote (49706)1/13/2000 3:36:00 PM
From: Anthony@Pacific  Read Replies (1) of 122087
 
SNRS<--changes approval request in such a way that it couldnt get turned down.now watch the tsock tank like a brick...

This is thge best news ,,now ther eis no more FDA crap to prevent the stock from falling all the way to zero ...when ther is no market for such a pathetic and minscule mkt.

This time, Sunrise presented data from two years instead of
18 months and changed the approval it sought.
Originally, Sunrise asked the Food and Drug Administration
to approve the three-second laser procedure for "correcting" mild-to-moder
hyperopia, the medical term for farsightedness. The company changed
that request to "reducing" mild-to-moderate hyperopia "where the
magnitude of correction diminishes over time."
The company's rationale: hyperopic patients over age 40 continue
to lose vision over time as the eye ages and loses elasticity,
making it unable to focus on objects near and far. These bifocal-wearing
patients, according to Sunrise, will continue to lose vision with
or without a laser procedure.
The FDA, which doesn't have to follow the panel's advice, will
make final decision on the product and its specific approval.

Sunrise's study showed that some patients still needed to wear
glasses or contacts after the surgery. Also, the procedure worked
better on older patients than it did on younger ones.
Sunrise said about 37 million of the nation's 60 million farsighted
people fall into the mild-to-moderate range and will therefore
be eligible for the procedure.
The laser works by sending two separate rings of eight lasers
into the eye around the field of vision. This warms the collagen around the cornea, causing it to shrink and change shape.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext